Cross-species comparative gene expression profiling suggested that similar to MLL-AF9 driven AML in mice, some AML patients (not only those carrying MLL-fusions) expressed similar EMT-related genes associated with poor outcome [65]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.